scispace - formally typeset
Y

Yujean Lee

Researcher at KAIST

Publications -  7
Citations -  45

Yujean Lee is an academic researcher from KAIST. The author has contributed to research in topics: Downregulation and upregulation & Microbolometer. The author has an hindex of 3, co-authored 7 publications receiving 27 citations.

Papers
More filters
Journal ArticleDOI

PD-1 and TIGIT downregulation distinctly affect the effector and early memory phenotypes of CD19-targeting CAR T cells.

TL;DR: In this paper, a two-in-one CAR T approach was proposed, where two checkpoint receptors were downregulated simultaneously by a dual short hairpin RNA cassette integrated into a CAR vector, and the PD-1/TIGIT-downregulated CAR T cells generated from diffuse large B cell lymphoma patient-derived T-cells also showed robust antitumor activity and significantly improved persistence in vivo.
Journal ArticleDOI

CMOS TDI readout circuit that improves SNR for satellite IR applications

TL;DR: In this article, a novel CMOS readout circuit for a satellite infrared time delay and integration (TDI) array is proposed, and a dead pixel elimination circuit solving a critical problem of the TDI scheme is integrated within a chip.
Journal ArticleDOI

Pixelwise readout circuit with current mirroring injection for microbolometer FPAs

TL;DR: In this article, a pixelwise readout circuit for microbolometer focal plane arrays (FPAs) is proposed, and a current mirroring injection input circuit that is suitable for a pixel-wise architecture and has high responsivity is proposed.
Proceedings ArticleDOI

Pixelwise readout integrated circuits with pixel-level ADC for microbolometers

TL;DR: In this paper, a pixel-level analog-to-digital converter (ADC) was proposed for 320 × 240 microbolometer focal plane arrays (FPAs) to decrease the thermal noise.
Posted ContentDOI

Simultaneous, cell-intrinsic downregulation of PD-1 and TIGIT enhances the effector function of CD19-targeting CAR T cells and promotes an early-memory phenotype

TL;DR: A lentiviral two-in-one CAR T approach in which two checkpoint receptors are downregulated simultaneously by a dual short-hairpin RNA (shRNA) cassette integrated into a CAR vector demonstrates that the cell-intrinsic PD-1/TIGIT dual downregulation strategy may prove effective in overcoming immune checkpoint-mediated resistance in CAR T therapy.